Spire Healthcare Group (LON:SPI) had its price target raised by Liberum Capital from GBX 125 ($1.64) to GBX 133 ($1.75) in a research note published on Monday morning, Stock Target Advisor reports. Liberum Capital currently has a hold rating on the stock.

Several other equities analysts have also issued reports on SPI. Peel Hunt reaffirmed an add rating and set a GBX 155 ($2.04) price objective on shares of Spire Healthcare Group in a report on Wednesday, January 8th. UBS Group reaffirmed a neutral rating and set a GBX 120 ($1.58) price objective on shares of Spire Healthcare Group in a report on Monday, September 16th. Peel Hunt reaffirmed an add rating and set a GBX 155 ($2.04) price objective on shares of Spire Healthcare Group in a report on Tuesday, January 7th. Jefferies Financial Group reaffirmed a hold rating on shares of Spire Healthcare Group in a report on Friday, November 15th. Finally, Barclays reaffirmed an underweight rating on shares of Spire Healthcare Group in a report on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of GBX 132.44 ($1.74).

Shares of SPI stock opened at GBX 137.90 ($1.81) on Monday. The stock’s 50-day moving average is GBX 131.37 and its two-hundred day moving average is GBX 118.21. The firm has a market cap of $542.26 million and a price-to-earnings ratio of 34.47. Spire Healthcare Group has a 1 year low of GBX 95.25 ($1.25) and a 1 year high of GBX 145 ($1.91). The company has a debt-to-equity ratio of 120.55, a quick ratio of 0.90 and a current ratio of 1.15.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Further Reading: What does the Producer Price Index (PPI) tell investors?

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.